CogniCurrent

COGNICURRENT

Feb 5 • 10:01 UTC • 🇦🇷 Argentina • Clarin (ES)

How the drugs that will revolutionize obesity treatment work

Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.

#obesity #semaglutide #tirzepatide #pharmaceuticals #spain
Read Original Back to Feed

📡 Similar Coverage